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GLUCOCORTICOID---RESPONSIVE HEPATIC CYTOCHROMES P-450 IN THE RAT: 
MULTIPLICITY AND DIFFERENTIAL REGULATION 
ABSTRACT 
A thesis submitted in partial fulfillment of the requirements for the 
degree of Doctor of Philosophy at Virginia Commonwealth University. 
Keith A. Hostetler 
Virginia Commonwealth University 
Philip S. Guzelian, M.D., Advisor 
The multiplicity of glucocorticoid-responsive hepatic cytochromes 
P-450 in the rat was investigated by developing a series of monoclonal 
antibody probes directed against purified steroid-inducible isozymes 
from the rat (P-450p) and man (HLp). Two antibodies, termed 1G8 and 
13-7-10, showed unique specificity for purified cytochromes P-450 upon 
immunoblot analyses. These antibodies were further characterized in 
terms of their reactivity toward proteins in liver microsomes from 
untreated and xenobiotic-treated rats. Three P-450p-related proteins 
were identified using 1G8 and 13-7-10 to monitor the expression of 
P-450p family subtypes. In untreated rats, members of this family 
exhibited sex-specific expression. Treatment with various chemicals 
resulted in differential induction of the 1G8- and 13-7-10-reactive 
proteins, demonstrating distinct regulatory features of these 
immunochemically-related proteins. While searching for novel inducers 
of the P-450p family, the imidazole antifungal drug clot rimazole was 
vi 
found to significantly increase total cytochrome P-450. Detailed 
studies were undertaken to investigate the mechanism by which 
clotrimazole and other antifungal drugs induce hepatic cytochrome 
P-450. The effect of treatment of rats with the antifungal drugs 
clotrimazole, miconazole, or ketoconazole on the expression of three 
distinct P-450 gene families (glucocorticoid-responsive P-450p, 
phenobarbital-responsive P-450b/e , and ethanol-responsive P-450j) was 
determinded by measuring: 1) microsomal enzymatic activities with 
marker substrates, 2) the microsomal content of immunoreactive 
cytochromes P-450 with specific antibodies, and 3) the amounts of liver 
RNA hybridizing to cloned P-450 cDNAs. These studies establish that 
P-450p is the predominant P-450 isozyme induced by clotrimazole, 
miconazole, and ketoconazole. Two of these drugs, clotrimazole and 
miconazole also induced P-450b/e , whereas ketoconazole induced P-450j. 
Differential increases in specific P-450 mRNAs and prote ins resulted 
from treatment of rats with these imidazol e antifungal d rugs, 
suggesting that multiple cellular events are involved t heir mechanism 
of P-450 induction. In conclusion, expression of the P-450p family of 
cytochromes P-450 in rat liver is under complex regulatory control and 
is subject to modulation by clinically useful drugs. 
© Keith A. Hostetler 1988 
All Rights Reserved 
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INTRODUCTION 
Metabolism of foreign chemicals including drugs and other 
xenobiotics, along with important endogenous compounds, is dependent on 
catalysis by hemeproteins abundant in the endoplasmic reticulum of 
hepatocytes collectively termed the cytochromes P-450 (Guengerich, 
1979; Lu & West, 1980; Conney, 1982; and Coon & Koop, 1983). The 
unusually broad substrate specificity exhibited by these enzymes is 
partially accounted for by the existence of multiple forms, or 
isozymes, each encoded by a seperate gene (Adesnick & Atchison, 1985). 
Another important feature which imparts versatility to this enzyme 
system is that some, but not all isozymes of cytochrome P-450 are 
inducible (Guengerich et al., 1982). Thus, in response to a given 
inducer, the concentration of one or more isozymes increases and then 
returns to untreated levels upon clearance of the inducer. Indeed, the 
inducibility of xenobiotic metabolism was the basis for early 
classification schemes of both cytochrome P-450 forms and chemicals 
identified as P-450 inducers. For example, isozymes of cytochrome 
P-450 were initially believed to fall into one of three classes, a 
"control" or untreated form, a form inducible by barbiturates such as 
phenobarbital, or a form inducible by aromatic hydrocarbons such as 
3-methylcholanthrene (Ryan, et al., 1979). 
As methods for isolating and purifying isozymes of cytochrome 
P-450 progressed, it became clear that rat liver contained more than 
three distinct forms of cytochrome P-450. Nevertheless, it remained 
customary to classify newly identified inducing chemicals as being 
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either "phenobarbital-like" or "3-methylcholanthrene-like ." A third 
prototype inducer, the catatoxic steroid pregnenolone-16a-carbonitrile 
or PCN, was subsequently identified and shown to induce a form of P-450 
distinct from those induced by either phenobarbital or 3-methylcholan-
threne (Elshourbagy & Guzelian, 1980). The major form of rat liver 
cytochrome P-450 induced by PCN, by definition termed P-450p, has since 
been the subject of extensive investigation and found to possess a 
number of unique features among P-450 isozymes. Studies of both 
cultured hepatocytes and the living rat have revealed that expression 
of P-450p is stimulated not only by PCN, but also by glucocorticoids, 
barbiturates, organochlorine pesticides, halogenated biphenyls, and 
macrolide antibiotics (Heuman et al., 1982; Schuetz et al., 1984; 
Schuetz & Guzelian 1984; Schuetz et al., 1986; Wrighton et al. 1985a). 
Moreover, functionally and structurally related cytochromes, or 
homologues, have been identified in all species examined to date 
including man (Wrighton et al., 1985b; Watkins et al. 1985). 
A growing body of evidence has accumulated recently suggesting 
that in rats, P-450p is only one member of a family of closely related 
isozymes. Indeed, it is clear that the cytochromes P-450 are encoded 
by a superfamily of genes that can be divided into distinct families 
based on genetic, regulatory, and structural similarities (Whitlock, 
1986; Nebert et al., 1987). In rat liver, one such family consists of 
8 or more genes, several of which encode proteins that are inducible by 
phenobarbital, including cytochromes P-450b and P-450e (Kumar & 
Adesnick, 1983). Likewise, 3-methylcholanthrene-inducible cytochromes 
P-450c and P-450d, and ethanol-inducible cytochrome P-450j are 
representatives of other distinct isozyme families (Ryan et al., 1979; 
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Nebert et al., 1987). Evidence for the existence of a "PCN family" of 
cytochromes P-450 includes the observation that liver microsomes 
isolated from dexamethasone-treated rabbits contain two immunoreactive 
protein bands recognized by polyclonal antibodies raised against either 
rat P-450p or the rabbit homologue P-450LM3c (Wrighton et al. 1985b). 
In the same report, Northern blot analyses of liver RNA isolated from 
PCN-treated rats revealed at least two mRNA species hybridizing to a 
P-450p cDNA. Southern blot analyses of either the rat or human genome 
with the P-450p cDNA probe verified the existence of sufficient 
hydridizable DNA to encode four or more P-450p-related genes (Watkins 
et al., 1986). Finally, Gonzalez and coworkers isolated and 
characterized two nearly identical but distinct cDNAs from rats treated 
with PCN (Gonzalez et al. 1985). The deduced amino acid sequence of 
one of these clones is identical with the N-terminal sequence of 
P-450p. Nevertheless, no single laboratory has succeeded in isolating 
and purifying more than one steroid-inducible cytochrome P-450 from rat 
liver. 
Based on these observations, it was hypothesized that multiple 
P-450p-related isozymes are expressed in rat liver. Chapter 1 of this 
thesis, entitled "Immunochemical Evidence for Multiple Steroid-
Inducible Hepatic Cytochromes P-450 in the Rat," describes the 
characterization of two highly specific monoclonal antibody probes 
which react with two subtypes of structurally similar steroid-inducible 
cytochromes P-450. The data presented demonstrates that, although 
these proteins share common structural features, they are under complex 
and discoordinate regulatory control. Expression of the P-450p family 
of proteins is shown to be dependent not only upon recent exposure to a 
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variety of inducing chemicals, but also upon gender. 
Studies undertaken to isolate and purify from rat liver one or 
more proteins distinct from but related to P-450p verified the 
extensive structural and physical similarities among members of this 
isozyme family. Indeed, each purification study has resulted in the 
co-purification of proteins from both subtypes of P-450p-like proteins. 
Nevertheless, a new and unique class of chemical inducers of hepatic 
cytochrome P-450 was identified in the course of screening novel 
inducing compounds. In Chapter 2, "Co-induction of Multiple Hepatic 
Cytochrome P-450 Proteins and mRNAs in Rats Treated with Imidazole 
Antimycotic Agents," three commonly used antifungal drugs are 
characterized in terms of their differential effects on the expression 
of three different families of hepatic cytochrome P-450. Investigation 
of the possible mechanism of induction of this class of compounds 
suggests that effects on both RNA and protein metabolism are involved. 
CHAPTER ONE 
Irrununochemical Evidence for Multiple Steroid-Inducible 
Hepatic Cytochromes P-450 in the Rat. 
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ABSTRACT 
It has been established that there are glucocorticoid-inducible 
hepatic cytochromes P-450 in the rat (P-450p), the rabbit (LM3c), and 
man (HLp) which share extensive structural, functional, and regulatory 
features, and that in rats, P-450p may be a member of a family of 
closely related cytochromes. Immunochemical probes to P-450p were 
prepared and a unique monoclonal antibody, lGB, was identified which 
recognizes purified P-450p, but neither purified LM3c nor HLp upon 
immunoblot analyses. Similar analyses of liver microsomes from 
untreated male rats revealed two lGB-reactive proteins, whereas liver 
microsomes from untreated females contained none. Another monoclonal 
antibody, 13-7-10, reacted specifically with LM3c and HLp, but not with 
P-450p. A single 13-7-10-reactive microsomal protein was detected in 
untreated male and female rats, the latter protein exhibiting a greater 
apparent molecular weight. lGB-reactive proteins were induced to the 
greatest extent by triacetyloleandomycin, followed by dexamethasone, 
chlordane, pregnenolone-16~-carbonitrile, and 2,4,2' ,4'-tetra-
chlorobiphenyl. In contrast, 13-7-10-reactive proteins were most 
strongly induced by dexamethasone, only moderately by triacetyloleando-
mycin and pregnenolone-16~-carbonitrile, weakly by chlordane and not at 
all by 2,4,2' ,4'-tetrachlorobiphenyl. In conclusion, the P-450p family 
in rat liver consists of three or more proteins that are structurally 
related and yet appear to be under distinct regulatory control. 
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INTRODUCTION 
The liver cytochromes P-450 are a superfamily of hemoproteins 
located in the endoplasmic reticulum of the hepatocyte that play a 
critical role in the biotransformation of a diverse array of endogenous 
substances, such as steroid hormones, as well as xenobiotics, such as 
drugs and carcinogens (Lu & West, 1979; Adesnik & Atchison, 1985). 
Families of cytochrome P-450 proteins have been identified based on 
their similarities in biochemical, immunochemical, and genetic 
characteristics, including their responses to prototypic inducers. For 
example, P-450b and P-450e are immunochemically and structurally 
similar hemoproteins that are coinduced in the liver of rats treated 
with phenobarbital or phenobarbital-like inducers (Kumar et al., 1983; 
Adesnik & Atchison, 1985). Likewise, P-450c and P-450d are products of 
homologous genes whose expression is stimulated by administration of 
3-methylcholanthrene and other polycyclic aromatic hydrocarbons 
(Adesnik & Atchison, 1985; Guengerich et al., 1982). 
Several years ago, this laboratory identified a unique form of 
cytochrome P-450 (Elshourbagy & Guzelian, 1980), now termed P-450p, 
that is inducible by the synthetic steroid, pregnenolone-16a-
carboni trile (PCN) and by steroids of the glucocorticoid class such as 
dexamethasone (Heuman et al., 1982; Schuetz et al., 1984). Cytochrome 
P-450p is structurally and functionally distinct from the 
"phenobarbital-inducible" and "methylcholanthrene-inducible" forms of 
cytochrome P-450, and yet P-450p is inducible by phenobarbital and 
"phenobarbital-like" inducers (Guengerich et al., 1982; Heuman et al., 
1982; Schuetz et al., 1986). Macrolide antibiotics represent a third 
group of compounds that induce P-450p (Wrighton et al., 1985a). 
Cytochromes immunochemically and functionally related to P-450p have 
been found in all species thus far examined (Wrighton et al., 1985b) 
including P-450 LM3c in the rabbit and P-450 HLp in man (Watkins et 
al., 1985). Cytochrome P-450p may be involved in important 
biotransformation reactions because it is conserved among mammalian 
species and is regulated by an endogenous inducer (corticosterone) 
(Schuetz & Guzelian, 1984). 
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It is now evident that P-450p is a representative of a multi-gene 
cytochrome P-450 family. Cloned cDNA's to P-450p hybridize to at least 
two liver RNA species in PCN-treated rats (Wrighton et al., 1985b) and 
to a sufficient amount of the rat genome to account for as many as five 
P-450p-related genes (Molowa et al., 1986; Hardwick et al., 1983). 
Until recently, the liver cytochromes isolated by others from PCN-
treated rats [P-450PB/PCN-E (Guengerich et al., 1982) and P-4502a 
(Waxman, 1986)] appeared to be the same as P-450p. Gonzalez and 
co-workers identified and isolated a PCN-inducible protein and 
corresponding cDNA (P-450PCN1) (Gonzalez et al., 1985) apparently 
identical to P-450p, and, in addition, have recently found a homologous 
cDNA (P-450PCN2) that differs from P-450PCN1 in its deduced 
NH2 -terminal amino acid sequence (Gonzalez et al., 1986). However, no 
laboratory has isolated more than one P-450p-related protein from a 
single species. Some apparently homogeneous preparations may, in fact, 
be mixtures of closely related polypeptides that cross-react with 
polyclonal antibodies. 
In the present study, monoclonal antibodies that recognize 
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selectively individual PCN-inducible hepatic cytochromes P-450 were 
prepared. On the basis of analyses of rat liver microsomes with these 
probes, it is concluded that rat liver contains multiple 
immunochemically similar P-450p-related proteins that di splay separate 
regulatory characteristics. 
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MATERIALS 
The polychlorinated and polybrominated biphenyl isomers, 
2,4,2' ,4'-tetrachlorobiphenyl and 2,4,5,2' ,4' ,5'-hexabromobiphenyl, 
were generous gifts from Dr. Stephen Safe and Dr. Stephen Aust, 
respectively. Chlordane and trans-nonachlor were gifts from Velsicol 
(Chicago, IL). Aroclor 1254 was obtained from Monsanto Co. (St. Louis, 
MO) and SKF-525A was provided by Smith, Kline, and French 
(Philadelphia, PA). Triacetyloleandomycin was a gift of Pfizer 
Laboratories (Brooklyn, NY) and PCN was provided by the Upjohn Co. 
(Kalamazoo, MI). Phenobarbital sodium was purchased from Amend Drug 
and Chemical Co. (Irvington, NJ); isosafrole from Fluka (New York, NY); 
HPLC-grade isopropanol from Burdick and Jackson (Muskegan, MI); 
spironolactone, trans-stilbene oxide, chlorpromazine hydrochloride, 
phenothiazine, diphenylhydantoin, metyrapone, dexamethasone, 
clofibrate, and corn oil from Sigma (St. Louis, MO); peroxidase-
conjugated anti-mouse IgG, rabbit anti-goat IgG, and goat peroxidase 
anti-peroxidase from Miles Scientific (Elkhart, IN); ni t rocellulose 
paper from Bio-Rad (Richmond, CA); and diaminobenzidine 
tetrahydrochloride from Pfaltz and Bauer (Stamford, CT). All other 
chemicals used were of reagent grade or better. 
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METHODS 
Animals and Treatments. Sprague-Dawley rats (100-150 g, Flow 
Laboratories, Dublin, VA, USA) were housed in pairs in wire bottom 
cages and given unlimited access to standard lab chow and water, unless 
otherwise indicated. All chemicals were dissolved in corn oil except 
chlorpromazine, phenobarbital, and isopropanol, which were dissolved or 
diluted in water, metyrapone, which was dissolved in 0.9% NaCl and 
triacetyloleandomycin, which was added to powdered chow. Single intra-
peritoneal injections of 2,4,2' , 4'-tetrachlorobiphenyl (500µrnoles/kg) 
and 2,4,5,2' ,4' ,5'-hexabromobiphenyl (500µrnoles/kg ) were given four and 
seven days, respectively, prior to microsome preparation. A single 
intraperitoneal injection was also given for Aroclor 1254 (300mg/kg) 
four days prior to microsome preparation. Daily intraperitoneal 
injections were given for spironolactone (lOOmg/kg), trans-stilbene 
oxide (300mg/kg), isosafrole (150mg/kg), chl orpromazine (40mg/kg), 
phenothiazine (lOOmg/kg), PCN (300mg/kg), diphenylhydantoin (50mg/kg), 
trans-nonachlor (46mg/kg), and chlordane (42mg/kg), each for four days 
and SKF-525A (80mg/kg) and clofibrate (400mg/kg), each for three days. 
Dexamethasone (300mg/kg) and isopropanol (15mmoles/kg) were given by 
oral gavage daily for four days and for one day, respectively; 
phenobarbital (0.1%) was administered in drinking water for 6 days; 
triacetyloleandomycin (1% w/w) was fed in powdered chow for 10 days; 
and metyrapone (500mg/kg) was given as a single intraperitoneal 
injection one day prior to microsome preparation. 
Each animal was fasted overnight and killed by decapitation. The 
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liver was perfused retrograde with cold phosphate buffered saline 
(PBS), pH 7 .4, excised and homogenized, and microsomes were isolated by 
differential centrifugation as previously described (Elshourbagy & 
Guzelian, 1980). The concentration of total CO-binding cytochrome P-
450 in the microsomal preparations and in the purified proteins was 
determined by difference spectroscopy as described by Omura and Sato, 
1964. Microsomal protein concentrations were determined 
colorometr i cally (Schacterle & Pollack, 1973). 
Rat cytochrome P-450p (Wrighton et al., 1985a), rabbit cytochrome 
LM3c (Koop et al., 1981), and human cytochrome HLp (Watkins et al., 
1985) were purified according to the indicated published procedures. 
Preparation of Antibodies. Five virus-free female Balb/c mice 
(15-18 g, Charles River Labs, Raleigh, NC) were each injected 
intraperitoneally with 50µg of purified P-450p in a 50mM potassium 
phosphate, 50mM EDTA, 20% glycerol buffer combined with an equal volume 
of Freund's complete adjuvant in a total volume of 0.2ml, followed 21 
days later by a 20µg boost. Six days after the boost, blood samples 
from the mice were pooled and serum was prepared and assayed for the 
presence of antibody by enzyme linked immunosorbent assay (ELISA). A 
final 20µg intravenous boost was performed 3 days prior to fusion. 
Spleen cells from one immunized mouse were fused with P3-X63-Ag8 
multiple myeloma cells and the resulting hybridoma were expanded in 
vitro. Limiting dilutions were carried out to isolate individual 
clones. These were tested for antibody production by ELISA, allowed to 
expand, and then injected intraperitoneally into female Balb/c mice (5 
X 106 cells per mouse) which had been primed with pristane (0.5ml 
intraperitoneally) two weeks previously. The resulting ascitic fluid 
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was collected 9 to 14 days later, centrifuged to remove cells, and then 
stored at -20° C. The second monoclonal antibody used in these 
studies, termed 13-7-10, was prepared by Dr. Kremers as described 
elsewhere (Beaune et al., 1985). 
A polyclonal anti-P-450p IgG raised in a goat was prepared as 
previously described (Elshourbagy et al., 1981). In some immunoblot 
experiments absorbed anti-P-450p was used. Briefly, liver microsomes 
prepared from a 3-methylcholanthrene-treated male rat were solubilized 
with cholate and bound to cyanogen bromide-activated Sepharose-4B (15mg 
microsomal protein/ml Sepharose-4B) (Cautrecasas, 1970; March et al., 
1974). The IgG fraction prepared from serum of a goat immunized with 
P-450p was incubated overnight with the immobilized microsomes (lOOmg 
IgG/ml of Sepharose-4B). The unbound IgG was collected and subjected 
to a second immunoabsorption step (25mg IgG/ml of Sepharose-4B) with 
liver microsomes prepared from an untreated female rat bound to the 
Sepharose matrix. 
Immunoblot Analysis. Quantitative analyses of immunoblots were 
performed as described previously (Schuetz et al., 1984). Briefly, 
microsomal proteins were electrophoretically separated in 10% sodium 
dodecylsulfate-polyacrylamide slab gels. After the initial two hours 
of electrophoresis, a different amount of purified protein standard was 
added to each well. Electrophoresis was then continued for an 
additional one to two hours. The resolved proteins were 
electrophoretically transferred to nitrocellulose paper and non-
specific protein binding sites were blocked by an overnight incubation 
of the nitrocellulose paper in PBS containing 3% bovine serum albumin 
and 10% calf serum. After a one hour exposure to the monoclonal 
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antibody, the blots were washed with cold PBS, incubated with 
peroxidase-conjugated anti-mouse IgG for 30 minutes, and washed again 
with PBS. The immunoreactive proteins were visualized with the use of 
diaminobenzidine in 0.006% hydrogen peroxide. The blots were scanned 
with a Ziess densitometer to determine the integrated optical density -
of each protein band. The amount of immunoreactive protein present in 
each microsomal sample was calculated from the linear portion of a 
standard curve derived from the densities of the purified proteins on 
the same blot. Qualitative immunoblots devel oped with goat anti-P-450p 
IgG required a 30 minute exposure to rabbit anti-goat IgG and a 30 
minute exposure to goat peroxidase anti-peroxidase with intervening PBS 
washes. 
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RESULTS AND DISCUSSION 
Monoclonal antibody 1G8 was selected because this unique probe 
reacted with purified rat P-450p on illUllunoblots but did not react with 
the purified homologous proteins, rabbit cytochrome LM3 c (Wrighton et 
al., 1985a) or human cytochrome HLp (Watkins et al., 1985) (Fig. 1). 
Nevertheless, these three homologous proteins are illUllunochemically 
related in being recognized by polyclonal antibodies raised against 
either P-450p (Fig. 2, top) or LM3c (Watkins et al., 1985). IllUl\unoblot 
analyses of liver microsomes from untreated male rats developed with 
1G8 revealed two narrowly separated proteins (Fig. 1). The more slowly 
migrating of the two 1G8-reactive proteins in untreated males had the 
same mobility as did purified P-450p (Fig. 3). In contrast, no 
proteins were detected in liver microsomes isolated from untreated 
female rats when immunoblotting was performed under conditions of 
complete transfer (Schuetz et al., 1984) (Fig. 1). When these 
conditions were exceeded, trace amounts of 1G8-reactive protein were 
observed indicative of very low level expression of P-450p in livers of 
untreated female rats (see Appendix, figure 1). 
Next, a second monoclonal antibody, 13-7-10, was characterized. 
This antibody reacts specifically with HLp, a glucocorticoid-inducible 
human liver cytochrome P-450 (Molowa et al., 1986). The reactivity of 
this monoclonal antibody was the opposite of 1G8 in that 13-7-10 
specifically recognized purified rabbit LM3c and human HLp, but did not 
recognize purified P-450p (Fig. 1). Immunoblots of rat liver 
microsomes developed with the 13-7-10 antibody revealed a reactive 
protein in both untreated males and untreated females (Fig. 1). A 
consistent finding was that the 13-7-10-reactive protein in females 
migrated more slowly than did the 13-7-10-reactive protein in males 
(Fig. 1). Thus, two distinct 13-7-10-reactive proteins can be 
distinguished on the basis of their mobilities and sex-specificities. 
One or both of these proteins may be inducible because dexamethasone 
treatment increased the amount of total 13-7-10-reactive microsomal 
protein in female rats (Fig. 1). 
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The possibility that the microsomal proteins recognized by these 
monoclonal antibodies are only coincidentally related to P-450p cannot 
be excluded. However, polyclonal antiserum directed against P-450p 
reacted not only with all three purified homologous proteins, P-450p, 
LM3c, and HLp, but also with a pair of closely migrating, but separable 
proteins, in rat liver microsomes from an untreated male rat and a 
second pair in microsomes from an untreated female rat (Fig. 2). When 
the antiserum was absorbed first against immobilized rat liver 
microsomes prepared from 3-methylcholanthrene-treated males and then 
against untreated females, the resulting antibody still reacted 
strongly with purified P-450p , but only weakly with LM3c and HLp and 
not at all with microsomes from untreated female rats (Fig. 2). Thus, 
it appears that LM3c, HLp, and the 13-7-10-reactive protein present in 
untreated female rats share one or more epitopes that are recognized by 
neither the 1G8 monoclonal antibody nor the absorbed anti-P-450p IgG. 
Finally, when portions of the same immunoblot were developed with 
the anti-P-450p antiserum or with one of the two monoclonal antibodies, 
the pair of !GS-reactive proteins in untreated male rats co-migrated 
exactly with the proteins identified by the polyclonal antiserum (Fig. 
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4). Likewise, the proteins identified by the 13-7-10 monoclonal 
antibody (one in untreated males and one in untreated females) 
exhibited electrophoretic mobility identical to those recognized by the 
polyclonal antiserum (Fig. 4). Therefore, the proteins reacting with 
the unabsorbed polyclonal antibody and the monoclonal antibodies are 
probably the same. There is no evidence to suggest that the faster 
migrating female protein which was recognized only by the unabsorbed 
polyclonal antibody is related to the P-450p family. Therefore, it is 
concluded that there are at least three related proteins expressed in 
the livers of untreated rats: P-450p, and the male- and 
female-specific 13-7-10-reactive proteins. It is possible that the 
faster migrating of the two !GB-reactive proteins in untreated males 
and the male-specific 13-7-10-reactive protein are the same, since both 
proteins exhibit similar electrophoretic mobilities. 
The next series of experiments investigated the effects of 
treatment of female rats with inducers of P-450p on the amounts of lGB-
and 13-7-10-reactive proteins as determined by quantitative immunoblot 
analyses of liver microsomes. Because it was not possible to 
sufficiently separate and individually quantitate the pairs of proteins 
in induced rats, the results are expressed as the total lGB- or total 
13-7-10-reactive proteins. These studies utilized only one dose of 
each compound at a level reported to be maximal for induction of 
CO-binding hemoprotein. TAO induced the !GB-reactive proteins to the 
greatest extent (>300-fold increase over the minimum detectable value) 
(Table 1). This is consistent with the results of previous experiments 
in which P-450p was quantitated by a polyclonal anti-P-450p IgG 
preparation (Wrighton et al., 19B5b). Other strong inducers of 
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1G8-reactive proteins were dexamethasone (90-fold), chlordane (85-
fold), PCN (79-fold), trans-nonachlor (63-fold), SKF-525A (41-fold), 
spironolactone (39-fold), metyrapone (32-fold), and 2,4,2' ,4'-
tetrachlorobiphenyl (20-fold) (Table 1). In contrast, TAO only 
moderately induced the 13-7-10-reactive proteins (21-fold increase) 
compared to dexamethasone (49-fold increase) (Table 1). Most striking, 
however, was the relative lack of induction of 13-7-10-reactive 
proteins by chlordane and trans-nonachlor, both of which were strong 
inducers of the 1G8-reactive proteins (Table 1). Similarly, SKF-525A, 
spironolactone, and metyrapone were strong inducers of the 1G8-reactive 
proteins but relatively poor inducers of the 13-7-10-reactive proteins 
(Table 1). In addition, 2,4,2' ,4'-tetrachlorobiphenyl only induced 
1G8-reactive proteins (Table 1). Weaker inducers of the 1G8-reactive 
proteins included isosafrole, phenobarbital, trans-stilbene oxide, and 
Aroclor 1254 (Table 1). Each of these compounds was a superior inducer 
of the 1G8-reactive proteins as compared with the 13-7-10-reactive 
proteins (Table 1). Phenothiazine, chlorpromazine, and isopropanol 
exclusively induced the 1G8-reactive proteins whereas 2,4,5,2' ,4' ,5'-
hexabromobiphenyl, albeit a weak inducer, produced similar increases in 
the 1G8- and 13-7-10-reactive proteins (Table 1). The responses of the 
1G8- and 13-7-10-reactive proteins to diphenylhydantoin and clofibrate 
were only marginal increases (Table 1). 
This laboratory previously demonstrated that there is a striking, 
qualitative difference in the regulatory control of P-450p-related 
proteins between species (Wrighton et al., 1985b). For example, 
rifampicin, the most efficacious inducer of P-450 LM3c in the rabbit, 
does not at all induce P-450p in the rat. Conversely, PCN, an inducer 
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of rat P-450p, is not an inducer of P-450 LM3c in the rabbit. In this 
study, using quantitative analyses, a striking difference was found in 
the profile of induction among apparently related proteins within a 
single species. For example, the organochlorine pesticides chlordane 
and trans-nonachlor, which strongly induced the 1G8-reactive proteins 
were weak inducers of the 13-7-10-reactive proteins (Table 1). Indeed, 
2,4,2' ,4'-tetrachlorobiphenyl appeared to exclusively induce 
1G8-reactive proteins (Table 1). Although preferential induction of 
cytochrome P-450 forms within a family has been demonstrated (Ryan et 
al., 1980; Thomas et al., 1983), an example of induction of one (or 
more) isozymes within an inducible family to the exclusion of other 
family members has not been previously reported. Thus it may be 
concluded that although the 13-7-10-reactive proteins are related to 
P-450p, they are subject to quantitatively and qualitatively distinct 
control. 
Gonzalez et ~ have reported differential regulation of two 
mRNA's encoding members of the PCN family (Gonzalez et al., 1986). 
They found that P-450PCN1 mRNA was undetectable in both untreated male 
and female rats but was readily inducible by PCN and dexamethasone. 
The homologous P-450PCN2 mRNA was present in untreated male and female 
rats, was inducible by phenobarbital, but was refractory to induction 
by PCN and dexamethasone. The reported expression of P-450PCN2 mRNA 
does not correspond to that of the immunoreactive proteins we have 
described because none of the 1G8- or 13-7-10-reactive proteins are 
present in both males and females and both groups of proteins are 
readily inducible by PCN or dexamethasone (Table 1). The resolution of 
these discrepancies awaits more complete characterization of the 
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multiple mRNA and protein species. 
The immunoquantitation results provide a basis for ruling out the 
possibility that the 13-7-10-reactive proteins might be previously 
characterized rat liver cytochromes. For example, cytochromes P-450b 
and P-450e are elevated 20- to 30-fold in phenobarbital treated rats 
(Waxman, 1986) which is inconsistent with the weak response of the 
13-7-10-reactive proteins to phenobarbital (Table 1). Likewise, it is 
unlikely that 13-7-10 recognizes cytochromes P-450c and P-450d, which 
are elevated 30-fold by Aroclor and 20-fold by isosafrole treatments, 
respectively (Waxman, 1986) (see Table 1). Cytochrome P-450 PB-C (P-450 
PB-1) (Guengerich et al., 1982; Waxman, 1986), which is induced by 
neither PCN nor Aroclor (Guengerich et al., 1982) can also be ruled 
out. Finally, rat liver cytochromes P-450a, P-450f, P-450g, P-450h, 
P-450i (Ryan et al., 1982; Ryan et al., 1984a; Ryan et al., 1984b), and 
P-450 UT-H (Larrey et al., 1984) are proteins which are not signifi-
cantly induced and actually may decrease following treatment with 
phenobarbital, PCN, isosafrole, and Aroclor (Guengerich et al., 1982). 
Vlasuk et al., 1982, used two dimensional gel electrophoresis to 
tentatively identify as P-450p a polypeptide that was barely detectable 
in untreated rats, was induced by PCN, isosafrole, SKF-525A, Aroclor 
1254, and trans-stilbene oxide, but was not induced by chlordane. This 
laboratory recently identified a protein that had mobility on two 
dimensional gel electrophoresis identical to that of P-450p, was 
recognized by polyclonal anti-P-450p IgG, and was induced by chlordane 
(Schuetz et al., 1986). Thus the polypeptide identified by Vlasuk and 
co-workers may represent a distinct member of a PCN family (Schuetz et 
al., 1986). The exact relationship between the latter protein and the 
P-450p-related proteins we have identified in the present report 
remains unclear since SKF-525A, isosafrole, and chlordane elevate the 
13-7-10-reactive proteins to approximately the same extent (about 5-
fold above the minimum detectable amount) and Aroclor 1254 and 
trans-stilbene oxide were only marginally efficacious inducers of 
13-7-10-reactive proteins (Table 1 ). 
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It was observed that 13-7-10-reactive proteins were only weakly 
induced by TAO (Table 1). This might reflect differences in substrate 
specificity of the 13-7-10-reactive proteins because the dramatic 
induction of 1G8-reactive P-450p in TAO-treated rats is associated with 
conversion of the drug by P-450p to a metabolite that binds P-450p 
specifically (Wrighton et al., 1985a ). In contrast, an agent has yet 
to be identified that elevates 13-7-10-reactive proteins more than the 
1G8-reactive proteins. The most effective in this regard is 
2,4,5,2' ,4' ,5'-hexabromobiphenyl, which elevated these proteins to a 
similar extent. Although no attempt was made to determine dose-
response relationships for the inducers, structural differences among 
the polyhalogenated biphenyls may account for the apparent preferential 
or selective induction of the two types of immunoreactive proteins 
(Table 2). Indeed, this laboratory recently demonstrated that induction 
of P-450p and P-450b/e by polychlorinated biphenyl isomers involves 
different structure-activity relationships (Schuetz et al., 1986) . 
In summary, based on immunoblot analyses of rat liver microsomes 
developed with the antibody preparations described , at least two 
heretofore unrecognized proteins distinct from but related to P-450p 
have been identified. Final proof that these proteins are products of 
separate genes will require their purification, structural elucidation , 
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and assessment of their immunoreactivity. Nevertheless, specific 
monoclonal antibodies provide strong albeit indirect evidence to add to 
the growing recognition that there is a family of "PCN 
inducible-cytochromes P- 450" expressed in rat liver. These proteins 
appear to be discoordinately regulated. They are under complex control 
by factors associated with gender and are i nfluenced to different 
extents by many structurally dissimilar exogenous compounds. The 
monoclonal antibodies described will be most hel pful in eventually 
achieving a complete structural desc ription of this unique family of 
proteins and the mechanisms of their regulation. 
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Table 1 
Quantitation with monoclonals !GB and 13-7-10 of immunoreactive 
cytochromes P-450 in rats treated with inducers. Female rats were 
treated and liver mic rosomes prepared and analyzed by quantitative 
immunoblotting as described in Methods. Results are expressed as 
densitometric units per microgram of microsomal protein and the 
corresponding fold increase over the lowest detectable valuea . Shown 
are the mean ± standard deviation of values obtained from three 
individual rats. 
Inducer lGB-reactive Fold Increase 13-7-10-reactive Fold Increase 
Control <0.007 <0.007 
TA Ob 2.230 ± 562 319 0.147 ± .040 21 
DEX 0.631 ± 121 90 0.341 ± .063 49 
CD 0.594 ± .129 85 0.034 ± .012 5 
PCN 0.555 ± .049 79 0.147 ± .029 21 
TNC 0.441 ± .065 63 0.028 ± .004 4.0 
SKF 0.284 ± .090 41 0.043 ± .006 6.1 
SLN 0.270 ± .071 39 0.044 ± .012 6.3 
MTP 0.223 ± .034 32 0.033 ± .013 4.7 
PCB 0.141 ± .040 20 <0.007 
ISF 0.110 ± .039 16 0.033 ± .022 4. 7 
PB 0.096 ± .021 14 0.049 ± .018 7.0 
TSO 0.081 ± .017 12 0.012 ± .005 1. 7 
ARO 0.078 ± .022 11 0.009 ± .022 1. 3 
PTZ 0.050 ± .019 7 <0.007 
PBB 0.040 ± .004 5.7 0.027 ± .017 3.9 
CLO 0.039 ± .008 5.6 0.009 ± .002 1. 3 
DPH 0.022 ± .008 3.1 0.009 ± .002 1. 3 
CPZ 0.019 ± .006 2.7 <0.007 
ISO 0.012 ± .005 1. 7 <0.007 
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Table 1 (cont'd.) 
8 Detection of 1G8- and 13-7-10-reactive proteins in mic rosomes isolated 
from untreated female rats requires analysis of samples that exceed 
the conditions established for quantitative electrophoretic transfer. 
The above values for fold induction are calculated as i ncreases over 
the lowest detectable value (.007 units/ ug) and thus underestimate the 
magnitude of induction. 
bAbbreviations used are: TAO, triacetyloleandomycin; DEX, dexameth-
asone; CD, chlordane; PCN, pregnenolone-16a-carbonitrile; TCN, trans-
nonachlor; SKF, SKF-525A; SLN, spironolactone; MTP, metyrapone; PCB, 
2,4,2' ,4' ,-tetrachlorobiphenyl; !SF, isosafrole; PB, phenobarbital; 
TSO, trans-stilbene oxide; ARO, arochlor; PTZ, phenothi azine; PBB, 
2,4,5,2' ,4' ,5'-hexabromobiphenyl; CLO, clofibrate; DPH , diphenyl-
hydantoin; CPZ, chlorpromazine; ISO, isopropanol. 
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Figure 1. Immunoblots of purified cytochromes P-450 and rat liver 
microsomes. Protein samples were electrophoretically resolved in 
polyacrylamide slab gels, transferred to nitrocellulose paper, and 
then developed with either monoclonal 1G8 (top) or 13-7-10 
(bottom) as described in "Methods". Shown are 1 µg each of 
purified rat P-450p, rabbit LM3c, and human HLp; 50 µg of 
microsomal protein from untreated rats, male (M) and female (F); 
and 10 µg of microsomal protein from a dexamethasone-treated 
female rat (DEX). 
IG8 
-
13-7-10 
P-450p LM3c HLp M F DEX 
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Figure 2. Specificity of anti-P-450p antibody before and after immuno-
absorption. Purified cytochromes P-450 and rat liver microsomes 
were analyzed by immunoblots, as described in "Methods", developed 
with either polyclonal anti-P-450p serum (top) or anti-P-450p 
antibody after 2X-immunoabsorption (bottom). Shown are 0.5 µg 
each of purified rabbit LM3c, human HLp and rat P-450p, and 50 µg 
of microsomal protein from untreated male (M) and female (F) rats. 
... --
-
LM3c Hlp P-450p M F 
Anti - P-450p 
antiserum 
2 x - absorbed 
antibody 
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Figure 3. Relative electrophoretic mobility of 1G8-reactive microsomal 
proteins with purified P-450p. Immunoblot of puri f ied rat P-450p 
(0.5 µg) and of microsomal proteins from an untreated male rat (M) 
(50 µg) and from a dexamethasone-treated female rat (1 µg) (DEX) 
developed wi th monoclonal antibody 1G8. 
P-450p M DEX 
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Figure 4. Analyses of rat liver microsomes by immunoblots developed 
with various antibodies. Shown are microsomal protein samples (50 
µg) from untreated male (M) and female (F) rats and microsomal 
protein samples (5 µg) from a dexamethasone-treated female rat 
(DEX). Prior to development, the immunoblot was cut into strips 
bisecting the lanes containing microsomal protein samples from 
untreated rats. Each strip was then developed with the indicated 
antibody, as described in "Methods". The dye front is shown to 
demonstrate proper realignment of the nitrocellulose paper. 
Anti-P-450p 
antiserum 13-7-10 
Anti-P-450p 
antiserum IG8 
DEX F M DEX F M DEX M DEX F 
CHAPTER 'IWO 
Co-induction of Multiple Hepatic 
Cytochrome P-450 Proteins and rnRNAs in Rats Treated 
With Imidazole Antimycotic Agents. 
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ABSTRACT 
To characterize the molecular basis by which imidazole antimycotic 
drugs increase cytochrome P-450, the effects of treating rats with 
clotrimazole, miconazole, or ketoconazole on expression of three forms 
of the hepatic cytochromes P-450 (P-450p, P-450b/e , and P-450j) were 
examined. From measurements of liver microsomal catalytic activities 
(demethylation of erythromycin, benzphetamine, or N-nitrosodimethyl-
amine), microsomal content of immunoreactive cytochrome P-450 protein, 
and the amounts of liver RNA hybridizing to cloned P-450 cDNAs, it was 
established that the glucocorticoid-responsive P-450p is the form 
predominantly induced by clotrimazole, miconazole and ketoconazole, to 
as much as 382 times above control values. The phenobarbital-
responsive cytochromes P-450b/e were induced modestly by clotrimazole 
and miconazole, but not at all by ketoconazole. In contrast, ethanol-
responsive P-450j was induced by ketoconazole but not by clotrimazole 
or miconazole. In several instances, treatment of rats with antifungal 
drugs resulted in accumulation of P-450 protein which significantly 
exeeded the corresponding increase in P-450 mRNA. Specifically, 
clotrimazole and ketoconazole disproportionately elevated P-450p and 
P-450j protein, respectively, whereas P-450b/e protein accumulated in 
excess of its mRNA following treatment with either clotrimazole or 
miconazole. From these results, it was concluded that imidazole 
antifungal drugs differentially modulate the expression of at least 
three distinct gene families of rat hepatic cytochromes P-450 by 
seperate mechanisms involving accumulation of cytochromes P-450 mRNA 
and hemeprotein. 
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INTRODUCTION 
Oxidative biotransformat i on of lipophilic compounds i s catal ysed 
by membrane-bound hemeproteins abundant i n the endoplasmi c reticulum of 
hepatocytes. The existence of multipl e isozyme forms of these 
cytochromes P-450 partially accounts f or the unusually broad substrate 
specificity exhibited by this enzyme syst em (Lu & West, 1980) . Indeed, 
the cytochromes P-450 are now recognized as a superfamily of isozymes 
which can be subdivided into distinct f ami l i es according to common 
structural, functional, or regulatory charact eri stics . Many of these 
isozymes are inducible by hormones , drugs, and other xenobiotics 
(Whitlock, 1986). For example, barbi turates such as phenobarbital, 
polycyclic aromatic hydrocarbons such as f}-napthofl avone, glucocorti-
coids and anti-glucocorticoids such as pregnenol one-16a- carbonitrile 
(PCN), and ketones and alcohols such as ethanol are exampl es of four 
di fferent classes of agents that selectivel y i nduce one of four 
different families of cytochrome P-450. 
Recently, N-substituted imidazole compounds have been shown to 
increase the total amount of cytochrome P-450 in the live r (Lavri jsen 
et al., 1986; Pershing et al . , 1986 ; Ritte r & Franklin, 1987). Several 
N-substituted imidazole derivatives a re well known to be pot ent 
inhibitors of oxidative metabol ism (Sheets et al . , 1986). These 
clinically useful antifungal agents i nterrupt synthesis of the major 
fungal sterol, ergosterol, at the cyt ochrome P-450- mediated step of 
lanosterol 14a-demethylation (Van den Bossche et al . , 1983). When one 
of these drugs, such as clotrimazole, miconazole , or ketoconazol e, is 
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administered to rats, liver microsomal oxidation of typical cytochrome 
P-450 substrates including erythromycin, aminopyrene, N,N-dimethylani-
line, or p-nitroanisole is increased (Lavrijsen et al., 1986; Pershing 
et al., 1986; Ritter & Franklin, 1987). Analysis of the profile of 
induced drug oxidizing activities suggests that clotrimazole may be a 
steroid-like inducer of cytochrome P-450 (Pershing et al., 1986; Ritter 
& Franklin, 1987), and miconazole may possess both steroid and 
phenobarbital inducing characteristics (Lavrijsen et al., 1986; Ritter 
& Franklin, 1987). However, ketoconazole induces a dis t inct profile of 
microsomal activities that do not resemble those from phenobarbital, 
steroid, or methylcholanthrene-treated rats (Lavrijsen et al., 1986). 
In the present study, the identity of the cytochrome P-450 
isozymes regulated by these N-substituted imidazoles was investigated 
not only by measuring microsomal drug oxidizing activities, but also by 
analyzing liver microsomes on immunoblots developed with specific 
antibodies directed against the major form(s) of cytochrome P-450 
induced by glucocorticoids (P-450p), by phenobarbital (P-450b/ e), or by 
ethanol (P-450j). In addition, Northern blot analyses of liver RNA 
were carried out to determine the amounts of mRNA hybridizable to 
cloned cDNA probes to P-450p, P-450b/ e, and P-450j. The results reveal 
that P-450p is the major cytochrome induced by clotrimazole, 
miconazole, and ketoconzole, and that the former two also induce 
cytochrome P-450b/e, whereas only ketoconazole induced P-450j. 
Moreover, there was a lack of proportionality between induction of 
immunoreactive P-450 protein as compared to increases in hybridizable 
P-450 mRNA suggesting that these antimycotics selectively induce some 
cytochromes P-450 by effects on both mRNA and protein metabolism. 
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MATERIALS 
Triacetyloleandomycin (TAO) and ketoconazol e were gifts from 
Pfizer Laboratories (Brooklyn, NY) and Janssen Pharrnaceutica 
(Piscataway, NJ), respectively. Erythromycin and d-benzphetarnine were 
purchased from the Upjohn Co. (Kalamazoo, MI); phenobarbital sodium 
from the Amend Drug and Chemical Co. (Irvington, NJ); clotrirnazole, 
N-nitrosodimethylarnine, dexarnethasone, S-napthoflavone, and miconazole 
nitrate from Sigma Chemical Co. (St. Louis, MO). Crisco brand 
cholesterol-free corn oil was purchased locally. Nitrocellulose was 
purchased from Bio-Rad (Richmond, CA); diarninobenzidine 
tetrahydrochloride from Pfaltz & Bauer (Stamford, CT); goat peroxidase 
anti-peroxidase from Miles Scientific (Elkhart, IN) and peroxidase 
anti-mouse IgG, peroxidase anti-rabbit IgG, and rabbit anti-goat IgG 
from ICN IrnrnunoBiologicals (Lisle, IL). All other reagents were of the 
finest grade commercially available. 
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METHODS 
Animals and treatments- Sprague-Dawley rats (175 - 225 grams, Flow 
Labs, Dublin, VA) were housed in pairs and given unlimited access to 
food and water. Each compound was suspended in corn oil (except 
phenobarbital, which was dissolved in 0.9% sodium chloride) and was 
administered to female rats by oral gavage (except phenobarbital and 
f3-napthoflavone, which were given by intraperitoneal injection). 
Miconazole (150mg/kg), ketoconazole (150mg/kg), clotrimazole (lOOmg/kg 
or 150mg/kg), phenobarbital (80mg/kg) and f3-napthoflavone (80mg/kg) 
were each administered daily for three days. Dexamethasone (300mg/kg ) , 
and TAO (480mg/kg) were given daily for three and five days, 
respectively. Vehicle-treated male and female rats were given corn oil 
(lOml/kg) for three days. Animals were fasted overnight and then 
killed by decapitation 24 hours after the final treatment unless 
otherwise noted. Each liver was perfused with iced phosphate buffered 
saline (PBS), pH 7.4, and then was excised and homogenized with a 
motor-driven teflon pestle in a buffer containing lOOmM Tris (pH 7.4) 
lOOmM KCl, lmM EDTA, and 20µM butylhydroxytoluene. Microsomes were 
isolated by differential centrifugation as previously described and 
stored immediately at -70°C (Elshourbagy & Guzelian, 1980). Total 
CO-binding hemeprotein content of each microsomal sample was determined 
as the dithionite reduced CO-difference spectrum (Omura & Sato, 1964 ) . 
The sample cuvette was saturated with CO for 60 seconds and sequential 
difference spectra were recorded until the absorbance at 450nm reached 
a maximum. Microsomes from TAO-treated rats we re decomplexed wi th 
K3 Fe(CN) 6 prior to the addition of carbon monoxide (Wrighton et al., 
1985a). Microsomal protein concentrations were determined 
colorimetrically (Schacterle & Pollack, 1973). 
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Isolation of Purified Proteins and Antibodies- Rat liver 
cytochromes P-450p (Wrighton et al., 1985b), P-450b (Waxman & Walsh, 
1982), and P-450j (Ryan et al., 1985) were purified according to 
indicated published procedures. A monoclonal antibody directed against 
purified P-450p was prepared and characterized as described (see 
Chapter 1). The polyclonal antibody directed against purified P-450b 
was raised in a goat as described (Elshourbagy et al., 1981) and then 
processed by sequential immunoabsorptions, first against liver 
microsomes from 13-napthoflavone-treated rats, and then against 
microsomes from untreated male rats. The polyclonal antibody directed 
against purified P-450j was raised in rabbits and characterized as 
indicated (Thomas et al., 1987). 
Microsomal N-demethylase Assays- Microsomal benzphetamine and 
N-nitrosodimethylamine N-demethylase activities were determined 
essentially as described (Guengerich, 1982). Briefly, 1.0 mg of 
microsomal protein from control or treated rats was incubated at 37° C 
in a lOOmM potassium phosphate buffer containing either 1.0 mM 
d-benzphetamine or 1.0 mM N-nitrosodimethylamine along with 
glucose-6-phosphate and glucose-6-phosphate dehydrogenase to generate 
NADPH. Erythromycin N-demethylase activity was measured as previously 
reported (Wrighton et al., 1985a) with erythromycin present at a final 
concentration of 0.4 mM and NADPH (40 mM final concentration) added 
exogenously. Enzymatic production of formaldehyde formed was 
determined colorimetrically using a Nash reagent (Nash, 1953). 
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Microsomes from TAO-treated rats were decomplexed with K Fe(CN) prior 
3 6 
to the initiation of the N-demethylase reactions. 
Immunoblot Analyses- Liver microsomes were resolved in 
polyacrylamide slab gels and blotted onto nitrocellulose filters under 
conditions described previously (Schuetz et al., 1984; and see Chapter 
1). After an overnight incubation in blocking solution consisting of 
PBS with 3% bovine serum albumin and 10% calf serum, development of 
each blot was initiated with a 60 minute exposure to the appropriate 
antibody. Exposure of blots to anti-P-450p antibody or anti-P-450j 
antibody was followed by a 30 minute incubation with 
peroxidase-conjugated anti-mouse or anti-rabbit IgG, respectively. 
Immunoblots developed with anti-P-450b antibody required sequential 30 
minute incubations with rabbit anti-goat IgG and peroxidase goat 
anti-peroxidase. Nitrocellulose filters were washed thoroughly with 
PBS between successive antibody incubations. Immunoreactive proteins 
were visualized with N,N-diaminobenzidine in 0.006% H2 0 2 • Quantitative 
immunoblot analyses included the appropriate purified cytochrome P-450 
(0.2 to 2.0 pmoles for purified P-450p and P-450b, and 1.0 to 6.0 
pmoles for P-450j). The integrated density of each immunoreactive band 
for both standards and samples was quantitated with a Zeiss 
densitometer as described (see Chapter 1). 
Isolation and Analyses of RNA- The P-450p (Wrighton et al., 
1985a), P-450b/e (Adesnik et al., 1981 ), and P-450j (Wrighton et al., 
1986) cDNA probes were isolated and chacterized in the indicated 
references. Total liver RNA from control or treated rats was isolated 
from a 0.5 g portion of liver using the guanidine isothiocyanate method 
(Elshourbagy et al., 1981; Deeley et al., 1977) . Northern blot 
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analyses were carried out as previously described (Wrighton et al., 
1985a). Briefly, aliquots of RNA from each animal were resolved by 
electrophoresis in agarose gels and then transferred to nitrocellulose 
filters. Each filter was baked under vacuum, prehybridized, and then 
incubated in a hybridization solution containing 32 P-labelled cDNA 
probes as described previously (Schuetz et al., 1986). Hybridization 
of the labelled cDNA probes to filter-bound RNA was visualized by 
autoradiography. Identical hybridization conditions we re utilized for 
quantitation, except that RNA samples were diluted and applied directly 
to nitrocellulose filters using a Schleicher and Schuell slot blot 
apparatus according to the manufacturers specifications. For each 
treatment group, a range of RNA (from 0.05 to 30µg) was analyzed. 
Autoradiography and scanning densitometry revealed a linear 
relationship between optical density of the hybridizati on signal and 
the amount of RNA analyzed. A slope was determined for each animal and 
was compared to the slope representing hybridizable mRNA from a control 
female rat analyzed on the same filter. 
Statistical methods- Two-tailed student t tests we re performed on 
unpaired sample means and the significance determi ned at two levels , 
p ~ 0.01 and p ~ 0.05. 
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RESULTS 
Effect of Treatments on Total CO-binding Cytochrome P-450-
Clotrimazole, miconazole and ketoconazole have each been identified as 
inducers of total spectrally determined cytochrome P-450 in previous 
reports (Lavrijsen et al., 1986; Ritter & Franklin, 1987) , although the 
maximum tolerated dose of each of these compounds has not been 
reported. Preliminary studies demonstrated that clotrimazole 
administered at 150mg/kg daily for three days produced a remarkable 
increase (5.1-fold) in total CO-binding cytochrome P-450 (Figure 1). 
This induction was even greater than that produced by triacetyloleando-
mycin (TAO) (Figure 1), a macrolide antibiotic inducer of P-450p which, 
until now, was the most efficacious inducer of rat live r cytochrome 
P-450 previously reported (Wrighton et al., 1985b; and Chapter 1). 
Treatment of rats with the maximum tolerated dose (150mg/kg) of 
ketoconazole or miconazole increased cytochrome P-450 over control 
values by 1.6 and 1.8-fold, respectively, similar to increases 
following treatment with dexamethasone (2.3-fold) or phenobarbital 
(1.9-fold) (Figure 1). It was observed that only 2 to 3 minutes was 
required to acheive the peak absorbance at 450nm after CO saturation of 
the sample cuvette, except for samples from clotrimazole-treated rats, 
which required 16 to 24 minutes (see Appendix, figure 2). Others have 
reported a slowly developing difference spectrum, indicative of 
competition between CO and a compound tightly bound to heme (Ritter & 
Franklin, 1987; Yoshida & Aoyama, 1987). To test this idea, female 
rats were treated with a reduced dose of clotrimazole (lOOmg/kg daily 
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for 3 days) and liver microsomes were isolated 42 hours (instead of the 
routine 24 hours) after the final clotrimazole treatment . The extent 
of induction of total CO-binding cytochrome P-450 in these microsomes 
was unchanged with the use of this prot ocol (data not shown). 
Nevertheless, despite the extended delay between the final clotrimazole 
treatment and microsome isolation, the putative residual competitor was 
still present, as evidenced by a requirement of 6 to 12 minutes before 
the CO-difference spectrum to reached a maximum. 
Effect of Treatments on Microsomal N-demethylase Activities-
Erythromycin N-demethylase (ERMD), a microsomal function known to be 
catalysed by P-450p (Wrighton et al., 1985b) was increased 7.3-fold 
above control values by clotrimazole treatment (Table 1 ). To reduce 
the interference by a residual competitor, (see preceeding paragraph), 
microsomes were isolated 42 hours after the last clotrimazole treatment 
for ERMD measurements. The magnitude of induction of ERMD by 
clotrimazole was similar to that produced by TAO and dexamethasone, two 
known inducers of P-450p (Table 1) (Wrighton et al., 1985a; see also 
Chapter 1). Miconazole treatment elevated ERMD activity to a lesser 
degree (2.2-fold, Table 1) whereas ketoconazole failed to induce ERMD 
activity (Table 1). The lack of detectable ERMD activity in 
microsomes isolated from ketoconazole-treated rats may be the result of 
low amounts of residual drug inhibiting P-450p as was obsersved with 
microsomes isolated 24 hours after the last clotrimazole treatment (see 
Appendix, figure 2). 
Microsomal benzphetamine N-demethylase (BNZD) activity, a marker 
of phenobarbital-responsive cytochromes P-450b/ e (Guengerich et al., 
1982), was stimulated to the greatest extent by treatment with 
phenobarbital (5 .8-fold ) or miconazole (5 .1-fold, Table 1 ) . 
Clotrimazole also significantly stimulated BNZD activity (3.2-fold ) 
whereas ketoconazole produced only a marginal increase (1.3-fold ) in 
this activity (Table 1). 
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N-nitrosodimethylamine (NDMA) N-demethylase activity, a marker of 
the ethanol-inducible rat cytochrome P-450j (Yang et a l ., 1985; Ryan et 
al., 1986; Levin et al., 1986 ) gave more variable results, but was 
increased the greatest by miconazole ( 3 times the value in female 
controls, Table 1), slightly by ketoconazole and not significantly by 
clotrimazole (Table 1 ) . 
Identification and Quantitation of Immunoreactive eytochromes 
P-450- Representative qualitative immunoblots of liver microsomes from 
control and induced rats probed with antibodies raised against purified 
cytochromes P-450p, P-450b, and P-450j are shown in Figure 2. As 
reported previously, the anti-P-450p monoclonal antibody 1G8 reacts 
with P-450p and with a faster-migrating protein expresssed in untreated 
male rats (see Chapter 1). The same bands are observed in microsomes 
from dexamethasone-treated female rats (Figure 3) . The 
faster-migrating protein expressed in untreated male rats and in 
induced female rats represents a P-450p-related protein (see Chapter 1 ) 
which has not yet been isolated and characterized . The present studies 
revealed that imidazole drugs induce two 1G8-reactive proteins as does 
dexamethasone (Figure 3). The strong induction of the upper protein 
band precluded acceptable resolution and seperate densitometric 
quantitation of the t wo immunoreactive proteins. The t wo bands 
measured as total anti-P-450p-reactive microsomal protein were markedly 
inceased (more than 380-fold over control values ) by clotrimazole 
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(Table 2). Clotrimazole induced imrnunoreactive P-450p in excess of 
that induced by TAO (221-fold, Table 2). Miconazole and ketoconazole 
were less effective inducers of imrnunoreactive P-450p (52- and 54-fold, 
respectively) and were intermediate between dexamethasone (124-fold ) 
and phenobarbital (26-fold, Table 2). The inductions of imrnunoreactive 
P-450p protein were accompanied by increases in ERMD activity except 
for microsomes from ketoconazole-treated rats in which ERMD activity 
remained unchanged from control values (Tables 1 and 2). 
The same liver microsomal samples were quantitatively analysed on 
imrnunoblots developed with anti-P-450b or anti-P-450j antibodies (Table 
2). Miconazole and clotrimazole induced imrnunoreactive P-450b/ e by 86-
and 102-fold, respectively, whereas ketoconazole did not induce 
P-450b/e protein (Figure 2, Table 2 ) . In contrast, among all the 
agents tested, only ketoconazole increased (2-fold) the level of 
immunodetectable P-450j (Table 2). NDMA N-demethylase activity was 
increased to a similar extent in the ketoconazole microsomes (Tables 1 
and 2). In contrast, miconazole treatment increased NDMA N-demethylase 
activity 3-fold even though immunoreactive P-450j protein was not 
elevated (Table 2). 
Analyses of Cytochrome P-450 mRNA- Representative Northern blots 
of liver RNA isolated from control and treated rats revealed 
differential hybridization signals depending upon which of the three 
P-450 cDNA probes was employed (Figure 4). The results of the 
quantitation studies, summarized in Table 3, showed that clotrimazole 
treatment increased hybridizable P-450p mRNA 93-fold over the control 
value, a rise much less than the corresponding 382-fold increase in 
immunoreactive P-450p protein (Tables 2 and 3). Similarly, TAO 
produced a disproportionate increase in immunoreactive P-450p protein 
(221-fold) as compared to hybridizable P-450p mRNA (45-fold, Tables 2 
and 3). In contrast, miconazole, ketoconazole, dexamethasone and 
phenobarbital each produced nearly identical increases over control 
values in P-450p immunoreactive protein and in hybridizable mRNA 
(Tables 2 and 3). 
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Less than proportionate increases in hybridizable P-450b/e mRNA as 
compared to total immunoreactive P-450b/e protein were also apparent 
following clotrimazole, miconazole, phenobarbital, or dexamethasone 
treatments (Tables 2 and 3). As expected, ketoconazole, which failed 
to increase either BNZD activity or immunoreactive P-450b/e protein, 
produced no change in hybridizable P-450b/e mRNA (Table 3). 
None of the agents tested increased hybridizable P-450j mRNA 
including ketoconazole, the only imidazole which induced immunoreactive 
P-450j protein (Table 3). The latter observation is consistent with 
reports that treatment of rats with pyrazole, acetone, or 
4-methylpyrazole increases immunodetectable P-450j protein and NOMA 
N-demethylase activity but does not incresase P-450j mRNA (Wrighton et 
al., 1986; Song et al., 1986). 
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DISCUSSION 
The results of this study demonstrate that N-substituted 
imidazoles including clotrimazole, miconazole and ketoconazole, 
represent a new class of inducers of the glucocorticoid-responsive 
family (Nebert et al., 1987) of hepatic cytochromes P-450 . These 
antifungal drugs increased ERMD, an activity linked to P-450p, induced 
one or more immunoreactive P-450p proteins, and increased the amount of 
liver mRNA hybridizing to a P-450p cDNA probe. Indeed, clotrimazole 
now supplants TAO as the most effective known inducer of total 
CO-binding hemeprotein and of P-450p (Wrighton et al., 1985b; see also 
Chapter 1). Exact identification of the subtypes of P-450p-related 
protein(s) induced by these antifungal drugs will require further 
study. 
The cytochrome P-450 inducing properties of the antimycotic drugs 
are not limited to members of the P-450p family. Catalytic, 
immunochemical and cDNA hybridization studies demonstrated that 
clotrimazole and miconazole, but not ketoconazole, are also effective 
inducers of the phenobarbital-inducible cytochromes P-450b/e. Indeed, 
at the doses administered, both miconazole and clotrimazol e proved to 
be as effective as was phenobarbital in increasing total P-450b/e 
immunoreactive protein and hybridizable P-450b/e mRNA (Tables 2 and 3). 
Clotrimazole and miconazole can be grouped along with compounds such as 
chlordane, transnonaclor, halogenated biphenyls, and phenoarbital as 
shared inducers of the steroid- and phenobarbital-responsive 
cytochromes P-450 and provide further evidence that, in rat liver, 
these two distinct families exhibit overlapping regulatory 
characteristics. This is in contrast to other families of cytochrome 
P-450, such as the aromatic hydrocarbon-inducible isozymes which 
exhibit stricter structure-acitvity requirements for inducibility and 
less overlap with inducers of other families of cytochrome P-450. 
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Several years ago, this laboratory investigated the mechanism 
underlying the dramatic induction of cytochrome P-450p by the macrolide 
antibiotic, TAO and found that in both hepatocyte cultures and in 
living rats, this drug selectively prolongs the half-li fe of P-450p 
(Watkins et al., 1986). Thus, TAO treatment results in a marked 
accumulation of P-450p protein while P-450p mRNA is inc reased only 
slightly (Wrighton et al., 1985b; Watkins et al., 1986). In the 
present studies, the administration of clotrimazole to rats also 
produced a disproportionately large increase in P-450p protein relative 
to the rise in hybridizable P-450p mRNA (Tables 2 and 3). Thus, it 
seems likely that clotrimazole, like TAO, inhibits the rate of 
degradation of P-450p. TAO is known to be converted by P-450p to a 
metabolite that then binds tightly to P-450p and inhibits its further 
catalytic activity (Wrighton et al., 1985; Pessayre et al., 1981). 
However, clotrimazole does not appear to form such a spectrally 
detectable complex with P-450p (Pershing et al., 1986). In this 
regard, clotrimazole resembles other types of P-450p inducers such as 
clordane or trans-nonaclor which increase the accumulation of P-450p 
protein to a greater extent than they increase its rate of de nova 
synthesis and yet do not form a stable metabolite complex with P-450p 
(Schuetz et al., 1986). In contrast to clotrimazole, miconazole and 
ketoconazole increased P-450p protein and mRNA to similar extents as 
did dexamethasone and phenobartibal (Tables 2 and 3). These findings 
suggest that the imidazole antifungal drugs may be useful probes for 
further study of the control of P-450p turnover. 
50 
A notable discrepancy became apparent when the magnitude of 
induction of P-450p mRNA and protein by dexamethasone observed in this 
study was compared with that reported earlier by Simmons and coworkers. 
These investigators found that a single dexamethasone injection 
increased hybridization of cytoplasmic poly(A) mRNA to a P-450PCN cDNA 
probe a maximum of 18-fold over control values, whereas chronic 
dexamethasone administration (80mg/kg daily for 4 days) elevated 
irnrnunodetectable P-450PCN protein only 4-fold (Simmons et al., 1987). 
In contrast, in the present study, dexamethasone was found to induce 
P-450p mRNA and protein 141-fold and 124-fold, respectively (Tables 2 
and 3). It is possible that differences in gender of rats treated, 
doses and routes of administration of the steroid, methods of 
immunoquantitation, and specificities of antibodies utilized may 
account for the observed discrepancies. 
As was the case with cytochrome P-450p, measurements of P-450b/e 
protein and mRNA following treatments with several inducers also 
revealed accumulation of immunoreactive protein in excess of 
hybridizable mRNA (Tables 2 and 3). In this regard, the imidazoles 
miconazole and clotrirnazole produced the greatest discrepancy, 
elevating P-450b/e protein 5.4 and 3.6 times more than hybridizable 
P-450b/e mRNA, respectively, as derived from data presented in Tables 2 
and 3. Less dramatic differences in accumulation of P-450b/e protein 
and mRNA resulted from phenobarbital or dexamethasone t reatments (a 
ratio of increase in P-450b/e protein to mRNA of 2.3 and 2.2, 
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respectively). It is noteworthy that Sirrunons and coworkers found a 10-
to 12-fold increase in hybridizable P-450b/e mRNA following 
dexamethasone treatment, nearly identical to the increase observed in 
the present study (Table 3, Sirrunons et al., 1987 ) . Moreover, in this 
same report, these investigators suggested the possible existence of a 
steroid-inducible P-450b-related protein (or proteins) that have not 
yet been identified (Sirrunons et al., 1987). Indeed, in the present 
studies, it was observed that dexamethasone induced a qualitativly 
distinct pattern of microsomal proteins recognized by the anti-P-450b 
antibody. As shown in Figure 2, the major anti-P-450b-reactive band in 
microsomes isolated from dexamethasone-treated rats exhibits a slightly 
greater apparent molecular weight than the major protein band induced 
by phenobarbital, miconazole, or cl otrimazole. Thus , the value 
reported for total irrununoreactive P-450b/e in microsomes from 
dexamethasone-treated rats reflects the presence of not only 
cytochromes P-450b and P-450e, but other immunochemically related 
proteins. 
The expression of cytochrome P-450j, another isozyme representing 
yet another cytochrome P-450 family, was stimulated by ket oconazole, 
but not by either clotrimazole or miconazole. Induction of P-450j by 
ketoconazole was evidenced by increases in both NDMA N-demethylase 
activity and immunodetectable P-450j, whereas levels of hybridi zable 
P-450j mRNA were unchanged by ketoconazole treatment (Tables 1, 2 and 
3). Thus, ketoconazole, like other inducers of P-450j, appears to 
affect the expression of this isozyme by post-translational mechanisms 
(Wrighton et al., 1986; Song et al., 1986). Moreover, it can be 
reasonably concluded t hat, as a class of P-450 inducers in the rat, the 
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N-substituted imidazoles are apparently capable of regulating at least 
three families of cytochrome P-450 isozymes by multiple mechanisms, one 
of which involves altered protein turnover. 
In summary, the present findings add to the growing body of 
evidence that N-substituted imidazoles represent a unique and important 
class of agents which have multiple effects on the expression of rat 
hepatic cytochromes P-450. These drugs will undoubtedly serve as 
useful as tools in the ongoing investigation of the molecular 
mechanisms involved in the regulation of the hepatic cytochromes P-450. 
Obviously, the doses of clotrimazole, miconazole and ketoconazole 
administered in this study far exceed clinically revelant doses of 
these compounds. Nevertheless, it is clear that the potential exists 
for significant alterations in human metabolism during antimycotic 
therapy. Indeed, there have been numerous reports of ketoconazole-
associated hepatic injury (Stricker et al., 1986). Recently, in 
addition to its use as an antifungal agent, this drug has been utilized 
as an inhibitor of steroid synthesis (Sonino, 1987) further emphasizing 
the importance of identifying the mechanisms by which ketoconazole and 
structurally similar compounds modulate the expression and functon of 
cytochromes P-450. Because clotrimazole and miconazole are primarily 
used topically thereby limiting systemic absorption, less has been 
reported about their effects on human metabolism. In conclusion, this 
study indicates that newly developed orally-administered N-substituted 
antimycotics should be carefully examined as possible modulators of 
oxidative metabolism in man . 
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Figure 1. Total Spectral P-450 in Liver Microsomes. Rats were treated 
0 
IJ') 
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ca 
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with inducers (BNF, 13-napthoflavone; DEX, dexamethasone; PB, 
phenobarbital; TAO, triacetylolandomycin; CTZ, clot rimazole; MCZ , 
miconazole; KCZ, ketoconazole) or vehicle (F, fema l e; M, male) as 
described in Methods. Liver microsomes were isolated by 
differential centrifugation and total spectral P-4 50 was 
determined by carbonyl-reduced difference spectroscopy . 
Sequential spectra were recorded until the absorbance maxium at 
450nm reach a maximum. In the case of microsomes from TAO-treated 
rats, K3 Fe(CN) 6 was added to a final concentration of 20 µM three 
minutes prior to carbon monoxide. Shown are the mean+ the 
standard deviation of values from five individual rats . 
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Figure 2. Immunoblot Analysis of Liver Microsomes Developed with 
Anti-P-450p. Microsomal samples were resolved electrophoretically 
in 10% SDS-polyacrylamide slab gels and then transf erred to 
nitrocellulose filters which were subsequently incubated with 
anti-P-450p antibody. Immunoreactive protein bands were visuali zed 
with diaminobenzidine. Shown are microsomal samples from a 
vehicle-treated male rat (M, 50 µg protein) and mi c rosomes 
isolated f rom female rats treated with either dexamethasone (DEX, 
3µg protein), clotrimazole (CTZ , l.5µg protein), mi conazole (MCZ, 
15µg protein) or ketoconazol e (KCZ, lOµg protein). Also shown is 
1.0 pmole of purified P-450p. 
M DEX CTZ MCZ KCZ P- 4 50P 
62 
Figure 3. Irnmunoblot Analyses of Liver Microsomes. Microsomal samples 
from control or induced rats containing the indicated protein 
quantities were electrophoresed, blotted, and then developed with 
the indicated antibodies as described in Methods. Also included 
are purified cytochromes P-450p (top panel), P-450b (middle panel) 
and P-450j (bottom panel). 
Anti-P-450p 
-
F M BNF DEX PB TAO CTZ MCZ KCZ ~ 
µg protein 35 10 I 
Anti-P-450b 
F M BNF TAO KCZ PB CTZ MCZ DEX P-450b 
35 I 0 '-----T--' µg protein 
Anti-P-450j 
------
F M BNF DEX PB TAO CTZ MCZ KCZ ~ 
µg protein 35 I 
Figure 4. Northern Blot Analyses of Hybridizable P-450 mRNA. Total 
liver RNA isolated from rats treated as outlined in figure 1 was 
subjected to electrophoresis in agarose gels, transferred to 
nitrocellulose filters and then hybridized with the indicated 
32 P-labelled cDNA probe as described in Methods. Hybridizable 
P-450 mRNA was visualized by autoradiography. 
cDNA PROBE 
P-450p 
F M BNF DEX PB TAO CTZ MCZ KCZ 
µg RNA 30 2 .0 
P-450b/e 
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µg RNA 30 20 2 . 0 
P-450j 
F M BNF DEX PB TAO CTZ MCZ KCZ 
µg RNA 30 
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DISCUSSION 
Since the isolation and purification of the major rat liver 
cytochrome induced by PCN reported by this laboratory (Elshourbagy & 
Guzelian, 1980), there has been extensive effort here and elsewhere to 
further characterize this protein and the mechanisms involved in its 
regulation. Strong, albeit indi rect evidence suggesting the existence 
of a "PCN family" of cytochromes in the rat, analogous to other 
families of inducible P-450 isozymes, prompted the development of a 
battery of immunochemical probes to carry out more definitive 
investigations. The results from these studies further establish that 
the P-450p family is unique among the families of rat liver cytochromes 
P-450 identified. 
On the basis of immunochemical evidence generated with highly 
specific monoclonal antibodies, it was concluded that at least three 
(and possibly four) P-450p-related forms are expressed in the liver of 
untreated rats. Both male-specific and female-specific members exist 
among these "control" forms of the P-450p family, an unusual feature 
among inducible cytochromes P-450 (Waxman, 1986). Moreover , expression 
of subtypes of P-450p-related proteins is differentially affected by 
xenobiotic inducers. In contrast, other inducible families of P-450, 
such as cytochromes P-450b and P-450e and cytochromes P-450c and P-450d 
rise in parallel in response t o phenobarbital and aromatic 
hydrocarbons, respectively (Adesnick & Atchison, 1985; Whitlock, 1986). 
Another striking feature of the P-450p family is the lack of 
structural similarity among chemical inducers that have been 
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identified. These include steroids, barbiturates , halogenated 
biphenyls, organochlorine pesticides, mac rolide antibiotics, and most 
recently, imidazole antimycotic agents. From this observation, it is 
clear that the regulation of this family of isozymes is complex. 
Indeed, multiple mechanisms have been implicated in the induction of 
the major form, P-450p. Hormonal regulation accounts f or the 
male-specific expression of P-450p in untreated rats (Waxman et al . , 
1985). Induction of P-450p by steroids clearly involves factors 
dissociated from the glucocorticoid receptor and possibly invol ves a 
unique "PCN receptor" (Scheutz & Guzelian, 1984). It i s known that PCN 
stimulates the rate of transcription of the gene encoding P-450PCN 
(Hardwick et al., 1983) presumably t he same protein as P-450p 
(Hostetler et al., 1987). It is noteworthy that dexamethasone , a 
strong inducer of both subtypes of t he P-450p family, induces other 
P-450 isozymes, most notably P-450b/e , by prolonging the half-life or 
"stabilizing" messenger RNA (Simmons et al., 1987) . Thus, it is 
possible that a single agent, dexamethasone, may regul ate P-450p 
expression via multiple mechanisms. 
Another previously identified mode of induction of P-450p involves 
the selective prolongation of the half-life of this isozyme which 
occurs following administration of t riacetyloleandomyci n . The result 
is a profound accumulation of P-450 protein, far in excess of the 
corresponding inc rease in P-450p mRNA (Watkins et al. 1986). In the 
present studies, a newly identified inducer of P-450p was found to 
markedly induce P-450p to a similar or even greater extent than does 
triacetyloleandomycin. Moreover , the disproportionate accumulation of 
P- 450p protein relative to mRNA following clotrimazole t reatment 
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strongly suggests t hat this drug also significantly retards the rate of 
P-450p catabolism. It is noteworthy that neither of the structural 
analogs miconazole nor ketoconazole share this apparent stabilizing 
effect on P-450p. Nevertheless, both clotrimazole and miconazole 
induce P-450b/ e protein in excess of the corresponding mRNAs, and 
likewise, ketoconazole increases P-450j protein but causes no increase 
in the level of P-450j mRNA. These observations by no means prove, but 
are consistent with the testable hypothesis that these imidazole 
antifungal drugs regulate multiple P-450 isozymes in a selective 
fashion by altering rates of hemeprotein turnover. 
Recent observatons in this laboratory suggest that the P-450p 
homologue in man, cytochrome HLp, is also a member of a multigene 
family. Thus, glucocorticoid-responsive cytochrome(s) P-450 in human 
liver not only serve as a useful model for further studies of the 
mechanisms of eucaryotic gene regulation, but also represent an 
important enzyme system prone to modulation by commonly used drugs 
including glucocorticoids, barbiturates, macrolide antibiotics, and 
imidazole antimycotic agents. Continued investigation i n this area 
will undoubtedly enhance basic understanding of this important enzyme 
system as well as provide a basis for rational and effective drug 
therapy. 
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APPENDIX 
Appendix Figure 1. Low level expresssion of P-450p in untreated female 
rats. Shown is an imrnunoblot of 50µg of microsomal protein from 
an untreated female rat (F) and 4.0µg from a clotrimazole-treated 
female rat (CTZ) developed with anti-P-450p monoclonal antibody 
1G8. As described in Chapter 1, the detection of imrnunoreactive 
P-450p in microsomes from untreated female rats requires the 
analysis of quanitities of protein which exceed the limit 
established for quantitative electrophoretic transfer, which is 
35µg. 
F CTZ 
74 
Appendix Figure 2. Time course for saturation of co binding to 
cytochrome P-450 in liver microsomes isolated from rats treated 
with clotrimazole at a dose of 150mg/kg daily for 3 days. 
Microsomes were isolated 24 hours after the last clotrimazole 
treatment. Microsomal suspensions were diluted to 1 . 0mg/ ml, 
reduced with sodium dithionite, and then split between sample and 
reference cuvettes of an Aminco DW-2a dual beam spectrophotometer. 
After a baseline recording, CO was bubbled through the sample 
cuvette for 60 seconds and then successive difference spectra 
between 360 and 510nm were recorded at the indicated time points. 
As described in Chapter 2, the slowly developing CO-difference 
spectrum is indicative of competition between CO and a compound 
tightly bound to heme. 
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